Author: pontus

Breakfast seminar September 12th in Lund: “Competitive advantages created by solid patent strategies”

19 August, 2018

For knowledge-intensive companies patent rights are a competitive advantage, and a patent strategy is a valuable key to secure investments. By considering and analyzing possible risks, challenges and opportunities, companies can reap considerable strategic advantages.
A patent strategy created by tailored advice and in-depth knowledge is the invaluable foundation to fully utilize the patent system and a basis for securing returns on investments.

Sign up here
Date: Wed, September 12, 2018
Time 8:00 AM – 10:00 AM CEST
Location: Scheelevägen 27, Gateway, våning 18, 223 63 Lund

A passive business will soon see its market share fall, its trademarks become diluted and its investments decrease in value. One aspect is to ensure that legal advise and measures are taken at an early stage. It is important to have a patent strategy and to revise the strategy as the company matures or changes direction. In order for the protection gained through exclusive rights to be effective, it is sometimes necessary to take legal actions against infringement. What sanctions that can be imposed on the infringer? What are the pitfalls and challenges that can be avoided or even benefited from?

Program
08:00-08:30 Registration and coffee
08:30-10:00 Seminar and Q&A

”The intangible assets of a company are often a significant part of the assets. In order for a company’s patent portfolio to become as strong and valuable as possible it is important that the invention is handled in an adequate way from the beginning. This requires a close cooperation between you as client and us as a patent consultants. Our aim is to produce a patent that gives the client the best value, and we are looking forward to giving you an insight and a taste of how we do it.”

Kristin Nilsson, European Patent Attorney at Ström & Gulliksson
Maria Weineisen, European Patent Attorney at Ström & Gulliksson

“When acquiring a patent portfolio the company of course needs to know the answer to the question “why”. This calls for a strategy on “how” the patents are meant to be used and what risks and opportunities that planned use would transfer back to the patent and the company. Here we need to address the issue of “when”. As a lawyer we always prefer to be there as early as possible, because that is when we can minimize risks and create additional business value in a cost efficient way for years to come.”
Magnus Dahlman, Partner at Advokatbyrån Gulliksson

Sign up here!

Arranged together with Ideon Science Park and part of their 35 years of Innovations celebration. 

Ström & Gulliksson receives top-ranking by IAM Patent 1000 2018

7 June, 2018

The latest edition of IAM Patent 1000 – The World’s Leading Patent Professionals 2018 is published and Ström & Gulliksson is happy to be ranked as ”Highly recommended” in Europe.
– The ranking confirms our position as one of Europe’s leading patent firms, says Rikard Roos, Managing Partner at Ström & Gulliksson.

Among other things, IAM mentions that Ström & Gulliksson is “A proficient outfit experiencing considerable growth” and that Ström & Gulliksson is ”/…/ a prime choice for instructions across the contentious/non-contentious divide and a favourite among pharmaceutical powerhouses for its technical support in litigation.”

– The most important service we have to offer is our patent attorneys. Their personal qualities are indispensable to the excellent relationship they form with our clients. Complex high profile cases and feedback from clients have contributed Ström & Gulliksson’s ranking this year, where several of our patent attorneys have also been mentioned as leading individuals in the field of patents, says Rikard Roos who made it to the rankings for the third consecutive year:

“For these players, dedicated, proactive and creative attorney Rikard Roos “quickly identifies and understands the relevant issues of any case; he plays an instrumental and inventive role in any high-stakes litigation team”.

Senior Partner Björn Andersson, also made it to the rankings for the third consecutive year:
“Electronics and computer technology savant Björn Andersson boasts an unrivalled breadth of talent; “vastly experienced in proceedings before the EPO”, the able prosecutor is valued for his non-contentious strategy and has also contributed his expertise to six separate IP litigations over the last 12 months. “With a good eye for detail and incredible technical knowledge, Björn adds value through his pragmatic and accessible style.”

Partner Christian Arkelius has also been listed for the second consecutive year:
Telecoms, media and technology expert “Christian Arkelius stands out from the crowd. Detailed and hands-on, he is the best kind of patent attorney and gets to grips with every aspect of an innovation. Top of the list when it comes to knowledge of European and Asian patent processes, he is also able to write US-style applications – a rare gift for attorneys outside of the United States”.

More information about IAM Patent 1000 here.

Ström & Gulliksson expands its footprint in the Swedish capital with the hire of a U.K./EP patent attorney

6 April, 2018

Ström & Gulliksson is happy to announce that Edmund Lobb, a registered U.K. and European patent attorney, will join our office in Stockholm in May.

Ed graduated from Imperial College London in 2008 with a master’s degree in Aeronautical Engineering, before obtaining his PhD in biomechanical flow. He joined his current patent law firm in London in 2012 and has worked with a range of clients from start-ups to internationally renowned companies. Ed has experience handling patent law matters over a broad range of technology, with particular experience in the aerospace, software and electronics fields.

Christian Arkelius, Partner and Head of the Stockholm office comments:

“We are very delighted to sign Ed for Ström & Gulliksson and can’t wait to get started to work together. As a European top-tier firm, it is important for us to expand our footprint in Europe. With the hire of Ed, we will be able expand our overseas service offerings even further, especially in the U.K. and in the U.S. Ed is a member of the CIPA in the U.K., which is highly recognized in the industry. This will be a further advantage for our local Swedish clients with business operations in the U.K. or in other commonwealth states.”

“I am delighted to be joining Ström & Gulliksson in Stockholm”, says Ed. “The chance to work in Sweden is an exciting one and, at Ström & Gulliksson, I will have the opportunity to work with some of the best attorneys in the business. I hope that I can bring a fresh approach and help the firm further improve its client offering both in Sweden and overseas.”

Client case study Invico Metanol AB: A strong patent led to the realization of a large-scale environmental improvement

7 February, 2018

Combining business acumen with environmental focus while seeing the bigger picture, Anders Eliasson, former head of development at Invico Metanol AB, has always based his view of innovation on commercial value linked to environmental improvements. Additionally, his strong commitment to protecting the environment has always been an important driving force.

“I have always prioritized contributing to discoveries that matter in the bigger picture. I am driven by questions such as: How do we increase the yield from a resource? How can we make use of by-products and increase their yield or refine them further?”

Working with Ström & Gulliksson gave Invico Metanol AB a strong patent and led to the realization of a large-scale environmentally beneficial solution for the pulp industry.

Our forests are a versatile natural resource that generates many by-products as waste. Historically, the pulp industry has produced a large part of Sweden’s emissions and, to this day, forest industry corporate groups struggle to find sustainable solutions for the long term. Enormous quantities of wood are required to make pulp and the methanol that is released usually ends up with all the other stuff that reeks in the water purification plant. Invico Metanol AB set out to find new efficient and innovative ways to remove sulphur and other impurities from the methanol.

“The methanol produced when pulp is made is usually considered a problem, and producers have had to resort to merely burning it. There was an old method for removing the foul smell of the methanol, but it was complicated and had limited use. Our patent may sound relatively simple: Instead of merely distilling the methanol, we have added a step where we use paraffin oil for extraction. The oil is purified using steam and can be used again,” says Anders Eliasson. As head of development at Veolia Nordic AB, he focuses on creating commercial value with environmentally beneficial solutions.

Finding the right patent consultant is crucial to both smooth collaboration and a solid end result

“A patent process is often lengthy and costly. That is precisely why choosing a patent consulting firm with people who really care is so important,” says Anders Eliasson. He went to elaborate on this as follows:

“Finding the right patent consultant is crucial to both achieving a solid end result and ensuring smooth collaboration from start to finish. Working with Magnus Berglund, we were able to focus on the right aspects from the outset and continue doing what we do best. He scrutinized our hypotheses and lab tests while guiding us through the process, paving the way for a strong patent.

The decisive factor was Magnus Berglund’s special interest in and knowledge of all areas of applied chemistry. His understanding of the interplay between business models and patent strategies was also essential.

“Working with a patent consultant who is genuinely interested in what we do, both from a technological and business perspective, and who commands documented knowledge of the field, laid the foundations for smooth collaboration.”

Anders Eliasson highlights three important things to consider at the start of a patent process:

  • Make sure that you, your employees and especially your business partners are aware that the process is usually lengthy, although it can be accelerated.
  • Initiate dialogue with your patent consultant early on.
  • Choose a patent consultant who truly gets you and your business.

“Magnus Berglund has been instrumental in helping us make the right decisions and spend our time and energy on the right things. His involvement early in the process and laser focus on the patenting process played a crucial role for us. He constantly reminded us of and helped us identify core issues such as: How large is the innovation scope? What is unique and new about this? What is the commercial value? What knowledge do we need to support the patent?”

Close dialogue required to create strong patent portfolio

When the company was in the process of deciding whether to produce and deliver systems or to sell the concept, it opted for the latter. Patenting this technology was a prerequisite. Now the patent has been sold to Andritz, a major Finnish supplier of machinery to industries such as paper and pulp.

“Having been there from the start makes it hard to let go, although selling the patent was definitely the right decision. It was getting too big for us and we wanted as many companies as possible to be able to use the technology. We had neither the time nor the resources to design and manufacture the systems needed to meet demand and enable our discoveries to really make a difference,” says Anders Eliasson. He can now take pride that large pulp mills are able to upgrade their plants with the environmentally beneficial technology he helped develop.

Grants from the Swedish Energy Agency were instrumental to the company’s development activities, as was close collaboration with industry partners the company won over.
“We funded part of the development activities with the help of companies who were given the right to use the technology for their own purposes.”

Magnus Berglund has been along for the whole journey and has offered strategic advice in addition to the patent process proper:

“As a patent consultant, I find it incredibly rewarding to be onboard from innovation to patent and beyond, and to help the company tap potential for commercial value. Anders Eliasson and his team worked hard on development while maintaining close dialogue with me to create a strong patent portfolio, which we achieved. We are now in an age where innovations that solve environmental problems are sought-after and there is great interest in the general public, among companies and at the political level. I consider it my responsibility to keep this in mind and stay well-informed.”

How to file patent applications in different jurisdictions

18 January, 2018

There is no shortage of pitfalls in patent law. The consequences of mistakes can often be very serious. In the worst case, granted patent rights can be revoked in a dispute as a result of poor ground work – especially when you file your first patent application in a jurisdiction where you shouldn’t.
“It’s critical that companies follow the correct “First Filing Restriction” guidelines since failure to follow national law in this regard could, in a worst case scenario, result in the loss of the patent,” says Christian Arkelius, Partner and European patent attorney at Ström & Gulliksson.

Applying for patents in today’s age of global scale international commerce and business is indeed a tricky thing. With product development taking place on a global scale and with teams being spread across the globe with team members having different nationalities etc you need to be aware of the requirements of each single country where you do your research and where the inventions are created.

“You need to be aware not only of the fact that different countries apply different rules when it comes to where it is allowed to file the first patent application for an invention, but you also need to know how to navigate all these different rules properly,” says Arkelius and emphasizes the importance of strategic intellectual property counseling in order to keep fully aligned with case law and developments in these areas.

“If you are a registered British company with British researchers who are working in China, you would have to file the first patent application for any of the team´s inventions created and developed in China at the local Chinese Patent Office.”

But it is even more complex than this, says Arkelius and explains the challenges of multinational research teams and groups:

“There are several stipulations that makes it even more complicated and these situations call for strategic advice. There are countries that stipulate that when a person or a company that is a national of that country files a patent application, the actual patent application must be filed in the country of that national. And in addition to this – this may be so regardless of where in the world the invention was actually created or developed.”

An example of a country that applies this rather unique requirement is Greece. In Greece, nationals are obliged to file the first patent application for an invention in Greece.

“Typically, and this makes things more complicated, the national laws of different countries are not always easily combined. Quite frankly, the different national laws are not always in harmony with each other. For example, the national law in Greece seems to disregard the fact that a Greece national may be working in a cross-national team of people for a Swedish-based company and, still, the Greece law restricts the first filing of this national to Greece. With the correct legal advice, our aim at Ström & Gulliksson is to help our clients to avoid potential legal hurdles in this respect. By providing early counseling and guidance in situations like this, our aim is to avoid potential future disputes or unenforceable patent rights.”

The restrictions might also depend on what technology the first patent application relates to. Many countries only apply first filing restrictions to technology that is or could be in the interest of the State in question or which relates to military technology or defense inventions. In contrast to the U.S and China with the “Made in the USA” and “Made in China” restrictions, the U.K. is one example of a country that applies this type of ‘narrower’ first filing restriction.

“There exist several purposes of this type of restriction, but the main one is to enable governments to approve inventions before they are being widely disseminated around the globe. An approval from the government gives the company freedom to file inventions anywhere in the world. In some countries, there are examples where failure to abide these restrictions concerning the first patent application has led to fines and even criminal proceedings which also is a proof of the value of patents and the importance of handling the process correctly.”

Some explanatory examples of situations that multinational companies need to take into consideration to meet requirements:

A British national inventor living in France? He could have to file the first patent application of the invention in France, even if the invention was developed in the UK. Why? Because France has a stipulation that the residents (applicants) of the country must file a first patent application in the country, regardless of their nationality.

A research group consisting of a few British inventors and one greek inventor? If the group includes a Greek inventor, then the first patent application for any inventions developed by the group should in theory be filed in Greece – according to Greek national law. It becomes trickier if the inventors created the invention in, e.g., the U.S. or in China.

Ström & Gulliksson provides tailored counselling in European patent law all over the world and we will guide and support you through the application process as well as through potential legal hurdles and disputes. Our authorised European Patent Attorneys have wide-ranging experience of European patent law. We also provide the service of summarising the restriction for each country, and give advice when it comes to nationals and residents include both natural and legal persons.

If you have any concerns about a jurisdiction – feel free to contact:
Christian Arkelius, Partner and European Patent Attorney at Ström & Gulliksson or any one else in our team.

This discussion is provided without guarantees and is not to be considered legal advice. We highly recommend seeking legal counsel in the country of invention.  Any invention which may have a military application or could be considered important to national security is likely restricted not only by a country’s patent laws, but also by export laws, which are not addressed here. 

Patent rights and commercialization—The key to developing a new cancer immune primer

17 January, 2018

The life sciences call for perseverance, time, and money as well as a willingness to think strategically about patents at an early stage. The Gothenburg-based company Immunicum which is developing a new cell-based therapy to treat cancer, appreciates the value of working with a dedicated and knowledgeable team. Immunicum has a long-standing collaboration with Ström & Gulliksson and their European patent attorney Magnus Berglund, because they have a full grasp of the interplay between business models and patent strategies.
“It is essential we have a proactive partner who understands our values ​​and core business,” says Carlos de Sousa, CEO of Immunicum.

With over 25 years of experience in the the pharmaceutical and biotech industry at a senior level, Immunicum’s CEO Carlos de Sousa knows how crucial it is to work with a skilled patent attorney. Especially, someone who is familiar with the entire process, from strategizing the patent application to legal advice in the event of a patent infringement suit.

“Our patents exist to protect us as much as possible because we operate in a particularly  specialized field. Furthermore,Immunicum is a relatively small company with only 13 employees, so we rely on the support of external experts. The immuno-oncology field we are operating in is very competitive, therefore our patent portfolio is critical to the success of the company.”

Immunicum is developing new immunological treatments for a range of solid tumours. The company’s method is to use allogeneic dendritic cells (another person’s cells rather than the patient’s), which are designed to activate and help the immune system attack the patient’s tumour.

“In addition to the protection secured by our patent portfolio, there is also other legislation that makes it hard for others to copy our results. Our patents are incredibly important, and we value proactivity in our current patent applications and in ensuring that our research results have the greatest possible protection. Ström & Gulliksson meets all our needs,” says Carlos de Sousa.

Tailored advice and a flexible IP-strategy

Magnus Berglund, European patent attorney and partner at Ström & Gulliksson, has worked closely with Immunicum for years:

“Our in-depth knowledge of international patent law means we offer tailored advice for all our customers. My focus is on providing Immunicum with strategic advice and guidance throughout the application process, and of course in its discussions with partners and in any litigation that arises. The moment for litigation usually comes after a product has been launched, but it is still important to have it in mind in the early stages of the patent process.”

Carlos de Sousa has extensive experience regarding patent applications in the US, Europe, and elsewhere, and is well aware of the importance of having a flexible IP strategy that can keep pace with the company.

“In the biotech industry, this is a major issue when gauging freedom to operate. I know the benefits of experience when handling potential conflicts with other companies operating in the same field. Additionally, it is important that your patent strategy takes into account the challenges that might arise at a later stage,” says Carlos de Sousa.

Professor Alex Karlsson-Parra, Immunicum’s co-founder and Chief Scientific Officer, has worked with transplant immunology for over 30 years and knows from experience when best to apply for a patent.

“Obviously, I knew from the start that I would need money if the research was to continue, but funding is not my strong suit. My focus has always been immunology in the widest sense, and in particular, how we can harness the body’s own immune system to attack cancer cells. That’s my contribution to Immunicum’s development. It’s been important for me to surround myself with people with real drive who are experts in other areas,” says Alex Karlsson-Parra, who values Immunicum’s long-standing collaboration with Ström & Gulliksson.

“The company has made significant progress thanks to Magnus’ advice and support in all our patent issues. His commitment to our research and results is outstanding, as is his knowledge of our core business.”

A strong patent portfolio is indispensable to reach the market

Immunicum today holds a number of important patents. Furthermore, an extended study known as a Phase 2 clinical trial, is currently underway across Europe and US. It is expected to finish in 2019.

“As for our collaboration with Ström & Gulliksson, it is based on an open, two-way dialogue. In order to put together a good patent application, I, as a researcher, have to be completely open and transparent, and that comes naturally when working with Magnus. Although his academic background is not in immunology, he has an impressive ability to understand this complex field, and he is a major factor in our ability to protect our discoveries and put our inventions in the right context,” says Alex Karlsson-Parra.

Magnus Berglund appreciates the challenge and the confidence that Alex Karlsson-Parra and Carlos de Sousa have placed in him over the years.

“As a patent consultant, it’s incredibly exciting to work with a biotechnology company like Immunicum. The most exciting research in cancer treatment today looks at drugs that stimulate the patient’s own immune system. For a relatively small company like Immunicum, which is ambitious and has excellent research results, a strong patent portfolio is indispensable. It means they can finance continued development so that the drug will eventually reach the market, and also ensures they have exclusive rights to the drug when it is launched,” says Magnus Berglund.

Carlos de Sousa’s plans for next year are already in place, including more clinical trials.

“Most of our time will be spent on clinical trials and on sourcing the funding to see them through. We will be starting the year determined to create change. The next few years will be very exciting in terms of advancing our lead compound ilixadencel through late-stage clinical development. We are determined to put all processes in place to bring this novel treatment to patients worldwide.”

We wish you a happy, non-stressful holiday season!

19 December, 2017

This year we donate a contribution to The Swedish Brain Foundation, Hjärnfonden, to support vital research on brain capacity, its diseases, injuries and disabilities, but also to increase knowledge about the development and potential of a healthy brain.

Best wishes from all of us at Ström & Gulliksson!

Case report: Preparation for patent infringement

12 October, 2017

Ström & Gulliksson Trainee Programme gets aspiring European patent attorneys off to a flying start

9 October, 2017

A solid basis of technical knowledge. A keen interest in seeing ideas realized. A drive to defend these ideas as if they were your own. These constitute solid foundations for those seeking to become patent consultants.
“Training to become a patent consultant involves developing the ability to see the big picture and the courage to challenge perceptions. Also, you need to be inquisitive and open,” says Maria Weineisen, a European Patent Attorney who serves as coordinator and lecturer with the Ström & Gulliksson Trainee Programme for new patent consultant hires.

Our newest Engineers Ida Moen Larsson and Georg Wolgast, are enrolled in the trainee programme and have already started to grasp the wide variety of tasks and challenges which patent work entails. Programme coordinator Maria Weineisen was recruited by S&G in autumn 2016 for her broad technical and scientific background in areas such as chemical engineering, organic chemistry, microbiology and immunology.

“Trainees learn a lot during the first weeks of the programme and gain a solid grounding in the patent process. After a while, they realize how incredibly complex patents are,” says Maria.

Over three terms, the trainee programme spans a variety of modules on everything from basic patent law to challenges in complex patent disputes. The trainees are also given the option of taking external courses.

“It’s inspiring to see the trainees’ passion for languages and technology paired with a laser focus on learning patent law,” says Maria.

Don’t be afraid to use 180-degree thinking
Working on the brainchildren of others requires not only substantial legal knowledge in the field of patents, but also vast technical knowledge and an outstanding grasp of language and style. You also need to be a good listener and strongly motivated to contribute to client success.

Each trainee is assigned a mentor and joins a group of patent consultants working in the same fields of technology. These working groups are small in size and the trainees are assigned to work alongside an experienced patent consultant at an early stage. Maria believes that more experienced patent consultants have a great responsibility to foster a workplace climate that is open and supportive. Happy employees who feel secure in their role tend to excel.

“The trainee programme encourages 180-degree thinking. Patents are complex, but if you know what you know for sure, what you might know, what you have a hunch about, and what you don’t know, then you’ll also know when you need to ask for help.  You won’t be able to grow or learn if you aren’t secure in your role.”

After completing the programme, trainees will continue their patent law studies and prepare for the European Qualifying Examination (EQE). After passing the examination, they may use the designation European Patent Attorney.

Thylabisco client case study: Scrutiny and clarity make for excellent patents

2 October, 2017

Research and passion for discovery. Formalities, a critical approach and patent applications. Although allowing someone to scrutinize, inspect and evaluate your research results at an early stage may give you pause, this is a must for ensuring a successful patent process.
“We have benefited substantially from the strategic advice and critical review of our results provided by Ström & Gulliksson. Magnus Berglund skilfully addressed the issues and discovered what was required to enable us to jointly compile and submit excellent patent applications,” says Charlotte Erlanson-Albertsson, Thylabisco AB, reflecting on many years of working with Ström & Gulliksson.

Thylabisco AB, which holds the patent, is run by Charlotte Erlanson-Albertsson, Professor of Medical and Physiological Chemistry at Lund University, and her husband Per-Åke Albertsson. The patent firm’s work for Thylabisco is characterized by ongoing dialogue. Their mutual understanding of timing and strategy has gradually improved over the years. The general appreciation and business opportunities of patents have increased, including within academia, with more and more people exploring opportunities to find investors at an earlier stage.

“However, most academics are driven by the desire to discover secrets and explore the world,” says Charlotte Erlanson-Albertsson, talking about her experience of her first years as a researcher:

“I remember when I was getting my doctorate and was completely immersed in my results. I went to sleep at night looking forward to the next morning. Overnight experiments are a real thrill. I’m still curious what the results will be, and working in an experimental field means that we constantly seek and are sometimes able to corroborate our theories.”

Thylabisco’s innovation is based on the discovery that thylakoids, a substance containing chlorophylls that is found in spinach and green leaves, delays digestion and releases satiety hormones in the intestines.

“I will never forget the Christmas when I came home and said to my husband, I need galactolipids, and he said, They can be found in thylakoids, and I have some in the refrigerator at my lab. And that’s how it all started,” says Charlotte Erlanson-Albertsson.

Thylabisco was born out of Charlotte’s interest in appetite control and the interaction between the intestines and the brain, which has played a leading role throughout her research career. Thus far, patent applications have been submitted for four effects: inhibiting fat absorption and reducing appetite, reducing sugar absorption, stimulating intestinal flora, and reducing sugar cravings.

“My dissertation focused on digestion, and I have indeed been previously involved in patent processes. This is actually the third time around and I’m super excited,” says Charlotte, who is the proud owner of a number of approved patents in several countries, although she rarely takes the time to slow down and celebrate her achievements.

“I try to remind younger scientists to buy cake and celebrate a little when an article is published. But I myself get most excited when a patent is approved; after that I put the impressive document away in a binder. An approved patent also means the clock is ticking and it’s normal to experience a degree of stress, although it’s a positive kind of stress, urging you on.

Turning discoveries into inventions
To Magnus Berglund, one of the most fascinating and stimulating parts of his job is defining what has actually been discovered in close collaboration with inventors.

“The dynamic between discovery, results and invention is at the heart of this type of project. Discoveries are not patentable per se, so you need to identify the new areas of application opened up by them,” says Magnus Berglund, who notes that the research community in particular suffers from the classic dilemma of applying for patents for something that has already been published in some form.

“There’s a difference between working for a for-profit company and someone from the world of academia. Companies often have one or more employees specifically scouting for patentability.”

Charlotte notes that academics live to publish. Applying for patents is often more of an afterthought for them. Most of the time they are more interested in disseminating their results and achieving an impact with them. Magnus Berglund is well aware of this way of thinking:

“It’s about finding a respectful balance between scrutiny and understanding. As a patent consultant, I have to quickly immerse myself in a context while scrutinizing and clarifying it to create a strong patent. Sometimes, parts of a patent application can share significant similarities with a scientific article,” Magnus Berglund explains.

Asking the right questions, finding the right comparison, but also suggesting additional experiments and further research are key parts of the process.

“When I suggest more experiments, the reason is usually to strengthen the patent application. If my client is a company with limited resources, I also intend for them to benefit from this further research in a strict business sense. This is why you gain a major advantage when strategically considering patents at an early stage to ensure they are brought into the business loop. This enables lab experiments to take into account the opportunity to develop favourable results ultimately leading to a commercial product,” says Magnus Berglund.

“From a patent perspective, having your results scrutinized can be fascinating and a bit discomforting. For me, it’s about the need to make my research and knowledge comprehensible and getting my findings out to the right people,” says Charlotte Erlanson-Albertsson, who dreams of success for many reasons:

“I dream of making a long-term contribution to groundbreaking research with a focus on a healthy lifestyle, benefiting both young and old. Women engaged in science would benefit from targeted financial support, and one of my visions is to create a foundation to this end. For creativity and inspiration to come into play you need to be able to focus all of your energy without having to worry about the noise around you and making ends meet.”

More about Thylabisco AB
The product is currently sold under the name BioCloose in Sweden as capsules to be taken every day. The main effect is to provide “a nice feeling of satiety and an end to rummaging through the pantry when you are tired and experiencing cravings.” This improves appetite control and reduces body fat. Thylabisco AB hopes to make new discoveries about the cognitive function of the brain and gain new patents. Bringing research results to the world is a return on society’s investment in education.